San Diego, CA, United States of America

Jill Melissa Scott

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Cardiff, CA (US) (2011 - 2013)
  • Poway, CA (US) (2014)
  • San Diego, CA (US) (2011 - 2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Jill Melissa Scott

Introduction

Jill Melissa Scott, based in San Diego, California, has made significant contributions to the field of pharmaceutical sciences with her impressive portfolio of nine patents. Her work focuses on revolutionary compounds that act as antagonists for lysophosphatidic acid receptors, highlighting her commitment to developing novel therapeutic solutions for various medical conditions.

Latest Patents

Scott's latest patents encompass compounds that serve as antagonists of lysophosphatidic acid receptor(s). These patents detail not only the compounds themselves but also pharmaceutical compositions and medicaments that incorporate these innovative compounds. Furthermore, she outlines methods for using these antagonists individually or in combination with other compounds, aiming to treat conditions that are dependent on or mediated by lysophosphatidic acid (LPA). This advancement is poised to have a significant impact on medical therapies addressing LPA-related diseases.

Career Highlights

Jill Melissa Scott's career includes key positions at notable companies such as Panmira Pharmaceuticals and Amira Pharmaceuticals. Her expertise and innovative spirit have allowed her to thrive in environments focused on cutting-edge research and development in pharmaceuticals. Over the course of her career, her dedication to exploring new avenues in medicinal chemistry has enabled her to secure numerous patents, underscoring her role as a leader in her field.

Collaborations

Throughout her career, Scott has collaborated with talented professionals, including Brian Andrew Stearns and John Howard Hutchinson. These partnerships have likely contributed to the innovative approaches she employs in her research and patent applications, fostering an environment of shared knowledge and creative problem-solving.

Conclusion

Jill Melissa Scott's journey as an inventor exemplifies the impact of dedicated research and innovation in pharmaceuticals. With nine patents to her name and significant work on lysophosphatidic acid receptor antagonists, her contributions continue to shape the landscape of modern medicine. As she navigates the evolving challenges of her field, her commitment to improving patient outcomes through novel therapeutic solutions remains steadfast.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…